NCT03375619View on ClinicalTrials.gov

Long-term Follow-up Study of Patients Receiving CAR-T Cells

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

January 1, 2035

Study Completion Date

January 1, 2035

Conditions
Chronic Lymphocytic LeukemiaLymphomas Non-Hodgkin's B-CellLymphoma, Small LymphocyticMantle Cell LymphomaCentral Nervous System LymphomaDiffuse Large B Cell LymphomaFollicular LymphomaBurkitt LymphomaMultiple Myeloma
Interventions
OTHER

Long-Term Follow-Up of Participants who Received CAR-T cells

No study drug is administered in this study. Participants who received CAR-T cells in a previous trial will be evaluated in this trial for long-term safety and efficacy.

Trial Locations (1)

53226

RECRUITING

Froedtert Hospital & Medical College of Wisconsin, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER